Australasian Gastro-intestinal Trials Group

This study tests whether adding a drug called sodium valproate to standard antibody therapy (panitumumab or cetuximab) can help control metastatic colorectal cancer longer. It involves 38 adults with a specific genetic type (RAS wild type) whose cancer has spread and cannot be cu…

This study looks at whether adding a targeted treatment (local ablative therapy) to standard first-line chemotherapy can help people with colorectal cancer that has spread to a few spots (oligometastatic) live longer without the cancer getting worse. About 6 participants whose ca…

This study tests whether adding an immunotherapy drug (durvalumab) to standard chemotherapy before surgery is safe and practical for people with pancreatic cancer that can be removed. About 20 adults with early-stage pancreatic cancer will receive the combination treatment. The m…